发布求助

文献互助智能选刊最新文献

Drugs - Real World Outcomes

查看最新文献

3333

WOS期刊分区历年影响因子历年发表同类期刊

影响因子：

1.9

ISSN：

print: 2199-1154
on-line: 2198-9788

研究领域：

PHARMACOLOGY & PHARMACY

自引率：

5.00%

Gold OA文章占比：

100.00%

原创研究文献占比：

91.53%

SCI收录类型：

Emerging Sources Citation Index (ESCI)

期刊官网：

https://link.springer.com/journal/40801

期刊介绍英文：

Drugs - Real World Outcomes targets original research and definitive reviews regarding the use of real-world data to evaluate health outcomes and inform healthcare decision-making on drugs, devices and other interventions in clinical practice. The journal includes, but is not limited to, the following research areas: Using registries/databases/health records and other non-selected observational datasets to investigate: drug use and treatment outcomes prescription patterns drug safety signals adherence to treatment guidelines benefit : risk profiles comparative effectiveness economic analyses including cost-of-illness Data-driven research methodologies, including the capture, curation, search, sharing, analysis and interpretation of ‘big data’ Techniques and approaches to optimise real-world modelling.

CiteScore：

CiteScore	SJR	SNIP	CiteScore排名
3.6	0.564	0.749	学科排名百分位大类：Medicine 小类：Pharmacology (medical) 141 / 272 48%

发文信息

WOS期刊分区

学科分类
Q3PHARMACOLOGY & PHARMACY

历年影响因子

2022年	2.0000
2023年	1.9000

历年发表

2014年	3
2015年	47
2016年	49
2017年	27
2018年	17
2019年	30
2020年	46
2021年	62
2022年	49

投稿信息

出版国家(地区)：

Switzerland

初审时长：

10 days

审稿时长：

8 weeks

出版商：

Springer Nature

PubMed链接：

http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2199-1154%5BISSN%5D

Drugs - Real World Outcomes - 最新文献

Adverse Reaction Reporting for Naxitamab in Chinese Expanded Access Treatment for Relapsed/Refractory High-Risk Neuroblastoma at the Children's Hospital of Fudan University.

Pub Date : 2025-03-01 DOI: 10.1007/s40801-024-00468-5 Xiaowen Qian, Dufei Zhang, Kai Li, Weiming Chen, Peijun Zhuang, Hongsheng Wang, Zhixian Lei, Yan Li, James Eldridge, Kuiran Dong, Xiaowen Zhai

Effectiveness and Safety of Vildagliptin Sustained Release in the Management of Type 2 Diabetes Mellitus: Real-World Evidence in Indian Patients [NOVELTY Study].

Pub Date : 2025-03-01 DOI: 10.1007/s40801-024-00473-8 Rakesh Sahay, Anil Bhansali, Surendra Kumar Sharma, Rahul Iyer, Amarnath Sugumaran, Senthilnathan Mohanasundaram, Jaideep Gogtay

Characteristics of Patients with Hereditary Angioedema Who Reduced Lanadelumab Treatment Administration Frequency: A Retrospective Observational Study of US Claims Data.

Pub Date : 2025-03-01 DOI: 10.1007/s40801-024-00470-x Nicole Princic, Kristin A Evans, Chintal H Shah, Krystal Sing, Salomé Juethner, Bob G Schultz

查看全部

免责声明：
本页显示期刊或杂志信息，仅供参考学习，不是任何期刊杂志官网，不涉及出版事务，特此申明。如需出版一切事务需要用户自己向出版商联系核实。若本页展示内容有任何问题，请联系我们，邮箱：info@booksci.cn，我们会认真核实处理。